Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
06/1993
06/24/1993WO1993012078A1 Azapeptides and a method for preparing same
06/24/1993WO1993012068A1 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
06/23/1993EP0548024A2 Aminosulphonic acid derivatives and process for their preparation
06/23/1993EP0547699A1 Peptidyl derivatives as inhibitors of interleukin-1B converting enzyme
06/23/1993EP0547342A1 Method for crystallization of alpha-L-aspartyl-L-phenylalanine methyl ester
06/23/1993EP0547178A1 Novel cholecystokinin antagonists, their preparation and therapeutic use
06/22/1993US5221752 α-keto amide derivatives
06/22/1993US5221670 Rapamycin esters
06/22/1993US5221667 Treating hypertension, hyperaldosteronism, congestive heart failure
06/22/1993US5221665 Prevent hydrolysis of elastin
06/21/1993CA2085840A1 Preparation of oligopeptide or amino acid alkyl ester.hcl salts
06/20/1993CA2085715A1 Aminosulfonic acid derivatives and processes for their preparation
06/20/1993CA2085300A1 Peptidyl derivatives as inhibitors of interleukin-1beta converting enzy eme
06/16/1993EP0546115A1 Peptides containing amino-polyols as transition-state mimics
06/16/1993EP0546108A1 Pro-drugs for cck antagonists
06/16/1993EP0545991A1 Peptides that block human immunodeficiency virus infections and methods of use thereof
06/16/1993EP0478729A4 Process for manufacturing aspartame from a diketopiperazine and novel intermediates and derivatives therefor
06/16/1993EP0471833A4 Method for increasing the alpha to beta ratio in an aspartame coupling reaction
06/15/1993US5220031 Chemical intermediate for title compound
06/15/1993US5219993 Method of recovering purified epi protein from a solution especially a fermentation solution
06/15/1993US5219988 Gem-diamino derivatives and their use in the synthesis of retro-inverso peptides
06/15/1993US5219851 Tetrahydroisoquinoline-type renin inhibiting peptides
06/10/1993WO1993011156A1 Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin
06/10/1993WO1993011154A1 Inhibitors of the conversion of big endothelin to endothelin
06/10/1993WO1993011152A1 New peptide derivatives
06/10/1993WO1993011104A1 Organic salts of n, n'-diacetyl cystine
06/10/1993WO1993010807A1 Hemoregulatory peptides
06/10/1993WO1993010747A2 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING
06/10/1993CA2124202A1 Hemoregulatory peptides
06/10/1993CA2123516A1 Organic salts of n,n'-diacetyl cystine
06/09/1993EP0545198A2 Peptides with insulin like activity
06/08/1993US5218089 Retro-inverso analogues of thymopentin and the method for their synthesis
06/08/1993US5217958 1,2-hydroxy phosphonates and derivatives thereof
06/08/1993US5217705 Method of diagnosing blood clots using fibrin-binding proteins
06/08/1993CA1318985C Amino acid 1,2-diketo derivatives as renin inhibitors
06/02/1993EP0544620A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP)
06/02/1993CN1021044C Preparation method for acidophobic-methyl propyl proline intermediate d-3-acetylsulfuric-2-methyl-propiony-l-proline
06/01/1993US5216125 Active ester used for production of acylated amino acids
06/01/1993US5216124 Analgesics
06/01/1993US5215968 Hypotension agents and viricides
06/01/1993US5215967 Aminoacid derivatives inhibiting renin
06/01/1993US5215966 For treatment of hypertension, hyperaldosteronism and cardiac insufficiency
06/01/1993CA1318751C Process for producing stable –-l-aspartyl-l- phenylalanine methyl ester
05/1993
05/27/1993WO1993010148A1 Muramyl compounds for treatment of septic shock
05/27/1993WO1993010144A1 New endothelin antagonists and their preparation
05/27/1993WO1993009795A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them
05/27/1993WO1993009668A1 Combinatorial strategies for polymer synthesis
05/27/1993CA2123395A1 New endothelin antagonists and their preparation
05/27/1993CA2117282A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprosing them
05/27/1993CA2083622A1 Certain macrocyclic lactam derivatives
05/26/1993EP0331756B1 Agents for prophylaxis and treatment of thrombopenia
05/25/1993US5214181 Immunodeficiency and autoimmune disease treatment
05/25/1993US5214129 Peptidylaminodiols
05/25/1993US5214032 Hair growth stimulants
05/25/1993CA1318461C Tripeptide derivatives
05/25/1993CA1318460C2 Process for the production of ó-aspartylphenylalanine derivatives
05/25/1993CA1318459C Imides, a process for their production thereof and a process for the production of dipeptides by using them
05/25/1993CA1318458C Preparation process of –-l-aspartyl-l-phenyl-alanine methyl ester having low hygroscopicity
05/25/1993CA1318457C Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them
05/25/1993CA1318456C Peptides
05/19/1993EP0542525A2 Antithrombotic agents
05/18/1993US5212163 Compounds
05/18/1993US5212160 Autoimmune disease, aging or bronchopulmonary disease
05/18/1993US5212158 Nootropic agents
05/18/1993US5212157 Tetrapeptides as inhibitors of HIV
05/13/1993WO1993009136A1 Phosphonopeptides with collagenase inhibiting activity
05/13/1993WO1993009135A1 Peptides inhibiting il-1 beta release
05/13/1993WO1993009134A1 Phosphonamidate ester-containing pseudopeptides
05/13/1993WO1993009133A1 C8-cyclic peptidomimetics as fibrinogen antagonists
05/13/1993WO1993009132A1 Hiv protease inhibitors containing guanidine
05/13/1993WO1993009101A1 Mercapto-amide derivatives as inhibitors of the neutral endopeptidase
05/13/1993WO1993008823A1 Guanidinyl and related cell adhesion modulation compounds
05/13/1993WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof
05/13/1993WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof
05/13/1993CA2122147A1 Phosphonepeptides with collagenase inhibiting activity
05/13/1993CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof
05/13/1993CA2116653A1 Peptides inhibiting il-1 beta release
05/13/1993CA2082748A1 Antithrombotic agents
05/12/1993EP0540626A1 Process for synthesizing peptides
05/12/1993CN1071930A Inhibitors of hiv protease useful for treatment of aids
05/12/1993CN1020612C Method for preparing antihypertensive tricyclic lactam derivs.
05/05/1993EP0539451A1 Vinylsulphonyl pristinamycin and preparation thereof.
05/05/1993EP0511302A4 Cytotoxic cell-specific protease-related molecules and methods
05/05/1993CN1020457C Process for the preparation of novel 1-methy1-4, 5-dihydroorotic acid derivative and pharmaceutical composition thereof
05/04/1993US5208230 Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
04/1993
04/29/1993WO1993008290A1 Enhanced immunogenicity using leukotoxin chimeras
04/29/1993WO1993008259A2 Inhibitors of dipeptidyl-aminopeptidase type iv
04/29/1993WO1993008211A1 Tripeptide derivative anti-inflammatory agents
04/29/1993WO1993001165A3 Aromatic compounds, compositions containing them and their use in therapy
04/28/1993EP0538882A1 Novel 2,5-dioxopiperazine compounds and method for preparing alpha-aspartyl-L-phenylalanine methyl ester derivatives
04/28/1993EP0538399A1 Cyclic cell adhesion modulation compounds
04/28/1993EP0538396A1 Inhibitors of retroviral proteases
04/28/1993EP0538383A1 Inhibitors of aspartic proteases
04/28/1993EP0538374A1 Aspartic protease inhibitors
04/28/1993EP0538366A1 Retroviral protease inhibitors
04/28/1993CN1071434A Retroviral protease inhibitors
04/28/1993CN1071333A Calcium receptor active molecules
04/27/1993US5206413 Method for preparing α-L-aspartyl-L-phenylalanine methyl ester
04/27/1993US5206384 Actinonin derivatives and pharmaceutically acceptable salts thereof
04/27/1993US5206343 Oligopetides with cyclic proline-analogous amino acids